Kim, Yoojoong https://orcid.org/0000-0003-2881-6856
Gumpper, Ryan H. https://orcid.org/0000-0003-1309-3069
Zhuang, Yuxuan
Dror, Ron O. https://orcid.org/0000-0002-6418-2793
Roth, Bryan L. https://orcid.org/0000-0002-0561-6520
Article History
Received: 22 May 2025
Accepted: 23 February 2026
First Online: 20 April 2026
Competing interests
: B.L.R. is a cofounder of ImprintBio, Lassogen and Epiodyne and a scientific advisory board member of Septerna and Lassogen. The University of North Carolina has licensed TRUPATH technology to many pharmaceutical and biotechnology companies. R.O.D. is a scientific advisor to Septerna. The other authors declare no competing interests.